Anti-CD20 monoclonal antibody therapies in relapsing multiple sclerosis: A systematic review and meta-analysis of randomised controlled trials.

Rituxan (rituximab) - Roche

Ocrevus (ocrelizumab) - Roche

Kesimpta (ofatumumab subcutaneous) - Novartis, Genmab

Briumvi (ublituximab-xiiy) - TG Therap

Ivlizi (divozilimab) - Biocad

http://www.ncbi.nlm.nih.gov/pubmed/42785004

Abeer Alatawi; Ahmed Salem Al-Dhahi; Amirah Alatawi; Saleem Almaser

Sep 25, 2026